Scott L Charland
- Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapyScott L Charland
School of Pharmacy, University of Colorado, 258 Leland Creek Circle, Box 1941, Winter Park, CO 80482 1941, USA
Curr Med Res Opin 26:365-75. 2010..With numerous treatment options for managing dyslipidemia, it is important to evaluate agents that result in the greatest reduction of CVEs...